153 related articles for article (PubMed ID: 27095502)
1. Vaccine adjuvant ginsenoside Rg1 enhances immune responses against hepatitis B surface antigen in mice.
Yuan D; Yuan Q; Cui Q; Liu C; Zhou Z; Zhao H; Dun Y; Wang T; Zhang C
Can J Physiol Pharmacol; 2016 Jun; 94(6):676-81. PubMed ID: 27095502
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg1 Activates Dendritic Cells and Acts as a Vaccine Adjuvant Inducing Protective Cellular Responses Against Lymphomas.
Huang Y; Zou Y; Lin L; Zheng R
DNA Cell Biol; 2017 Dec; 36(12):1168-1177. PubMed ID: 29058460
[TBL] [Abstract][Full Text] [Related]
3. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg1 and aluminum hydroxide synergistically promote immune responses to ovalbumin in BALB/c mice.
Sun J; Song X; Hu S
Clin Vaccine Immunol; 2008 Feb; 15(2):303-7. PubMed ID: 18094107
[TBL] [Abstract][Full Text] [Related]
5. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
Xie Y; Sun HX; Li D
Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model.
Mahdavi M; Mavandadnejad F; Yazdi MH; Faghfuri E; Hashemi H; Homayouni-Oreh S; Farhoudi R; Shahverdi AR
J Infect Public Health; 2017; 10(1):102-109. PubMed ID: 27026241
[TBL] [Abstract][Full Text] [Related]
7. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
[TBL] [Abstract][Full Text] [Related]
8. Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway.
Su F; Yuan L; Zhang L; Hu S
Vaccine; 2012 Jun; 30(27):4106-12. PubMed ID: 22472794
[TBL] [Abstract][Full Text] [Related]
9. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
Mutwiri G; Benjamin P; Soita H; Babiuk LA
Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
[TBL] [Abstract][Full Text] [Related]
10. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine.
Fakharzadeh S; Kalanaky S; Hafizi M; Goya MM; Masoumi Z; Namaki S; Shakeri N; Abbasi M; Mahdavi M; Nazaran MH
Vaccine; 2013 May; 31(22):2591-7. PubMed ID: 23583463
[TBL] [Abstract][Full Text] [Related]
11. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
[TBL] [Abstract][Full Text] [Related]
12. RLJ-NE-299A: a new plant based vaccine adjuvant.
Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K
Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726
[TBL] [Abstract][Full Text] [Related]
13. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N
Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626
[TBL] [Abstract][Full Text] [Related]
14. Platycodin D2 improves specific cellular and humoral responses to hepatitis B surface antigen in mice.
Xie Y; He SW; Sun HX; Li D
Chem Biodivers; 2010 Jan; 7(1):178-85. PubMed ID: 20087984
[TBL] [Abstract][Full Text] [Related]
15. Stereospecificity of ginsenoside Rg3 in promotion of the immune response to ovalbumin in mice.
Wei X; Chen J; Su F; Su X; Hu T; Hu S
Int Immunol; 2012 Jul; 24(7):465-71. PubMed ID: 22427454
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
[TBL] [Abstract][Full Text] [Related]
17. Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice.
Grenfell RF; Shollenberger LM; Samli EF; Harn DA
Clin Vaccine Immunol; 2015 Mar; 22(3):336-43. PubMed ID: 25609075
[TBL] [Abstract][Full Text] [Related]
18. Formulation of HBsAg in Montanide ISA 51VG adjuvant: Immunogenicity study and monitoring long-lived humoral immune responses.
Savoji MA; Sereshgi MMA; Ghahari SMM; Asgarhalvaei F; Mahdavi M
Int Immunopharmacol; 2021 Jul; 96():107599. PubMed ID: 33848910
[TBL] [Abstract][Full Text] [Related]
19. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg.
Khajuria A; Gupta A; Malik F; Singh S; Singh J; Gupta BD; Suri KA; Suden P; Srinivas VK; Ella K; Qazi GN
Vaccine; 2007 Jun; 25(23):4586-94. PubMed ID: 17498851
[TBL] [Abstract][Full Text] [Related]
20. PIKA as an adjuvant enhances specific humoral and cellular immune responses following the vaccination of mice with HBsAg plus PIKA.
Shen E; Li L; Li L; Feng L; Lu L; Yao Z; Lin H; Wu C
Cell Mol Immunol; 2007 Apr; 4(2):113-20. PubMed ID: 17484805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
